Bausch + Lomb Corporation announced that the Company and its CEO, Joseph C. Papa, have entered into an Amended and Restated Separation Agreement (the "Amended Separation Agreement"), pursuant to which Mr. Papa has agreed to continue serving as CEO until at least March 4, 2023 and lasting until such date as the Board of Directors of the Company determines in its discretion or his successor is appointed, but no later than June 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.24 USD | -0.65% | +3.67% | -10.67% |
05-28 | Bausch + Lomb's New Intraocular Lens Approved by Health Canada | MT |
05-28 | Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.67% | 5.36B | |
-8.49% | 175B | |
-1.08% | 107B | |
-7.69% | 65.05B | |
+2.81% | 50.76B | |
+6.66% | 43.14B | |
+5.93% | 41.46B | |
+18.48% | 30.69B | |
+13.37% | 25.39B | |
-5.39% | 23.69B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Bausch + Lomb Corporation Enters into CEO Separation Agreement with Joseph C. Papa